baseline

1
A Baseline On- treatment 56% decrease in pS6 staining B 30% decrease SUVmax in perihepatic disease C CA125 Response Observed

Upload: oliver-russell

Post on 30-Dec-2015

16 views

Category:

Documents


1 download

DESCRIPTION

A. Baseline. On-treatment. 56% decrease in pS6 staining. B. C. 30% decrease SUVmax in perihepatic disease. CA125 Response Observed. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Baseline

A

Baseline On-treatment

56% decrease in pS6 staining

B30% decrease SUVmax in perihepatic disease

CCA125 Response Observed